Literature DB >> 15774996

Monitoring in chronic disease: a rational approach.

Paul Glasziou1, Les Irwig, David Mant.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15774996      PMCID: PMC554914          DOI: 10.1136/bmj.330.7492.644

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  25 in total

1.  Dose response and safety of telmisartan in patients with mild to moderate hypertension.

Authors:  D H Smith; K M Matzek; J Kempthorne-Rawson
Journal:  J Clin Pharmacol       Date:  2000-12       Impact factor: 3.126

2.  How many measurements are necessary in diagnosing mild to moderate hypertension?

Authors:  M M Brueren; H Petri; C van Weel; J W van Ree
Journal:  Fam Pract       Date:  1997-04       Impact factor: 2.267

3.  The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.

Authors:  G H Guyatt; J L Keller; R Jaeschke; D Rosenbloom; J D Adachi; M T Newhouse
Journal:  Ann Intern Med       Date:  1990-02-15       Impact factor: 25.391

4.  An audit of requests for therapeutic drug monitoring of digoxin: problems and pitfalls.

Authors:  H W Clague; Y Twum-Barima; S G Carruthers
Journal:  Ther Drug Monit       Date:  1983       Impact factor: 3.681

5.  Regression towards the mean.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1994-06-04

6.  A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy.

Authors:  G Jannuzzi; P Cian; C Fattore; G Gatti; A Bartoli; F Monaco; E Perucca
Journal:  Epilepsia       Date:  2000-02       Impact factor: 5.864

7.  Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus--a randomized prospective study.

Authors:  R Rachmani; Z Levi; I Slavachevski; M Avin; M Ravid
Journal:  Diabet Med       Date:  2002-05       Impact factor: 4.359

8.  Learning difficulties of diabetic patients: a survey of educators.

Authors:  C Bonnet; R Gagnayre; J F d'Ivernois
Journal:  Patient Educ Couns       Date:  1998-10

9.  Motivational effect of cholesterol measurement in general practice health checks.

Authors:  I Robertson; A Phillips; D Mant; M Thorogood; G Fowler; A Fuller; P Yudkin; M Woods
Journal:  Br J Gen Pract       Date:  1992-11       Impact factor: 5.386

10.  Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial.

Authors:  B P A Thoonen; T R J Schermer; G Van Den Boom; J Molema; H Folgering; R P Akkermans; R Grol; C Van Weel; C P Van Schayck
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

View more
  60 in total

1.  Monitoring drug therapy.

Authors:  Thierry Buclin; Verena Gotta; Aline Fuchs; Nicolas Widmer; Jeffrey Aronson
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

2.  Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care.

Authors:  Jamie J Coleman; Sarah E McDowell; Stephen J W Evans; Paramjit S Gill; Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

3.  High quality care for people with chronic diseases.

Authors:  Trish Groves; Edward H Wagner
Journal:  BMJ       Date:  2005-03-19

4.  Monitoring therapy.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

Review 5.  Monitoring for adverse drug reactions.

Authors:  J J Coleman; R E Ferner; S J W Evans
Journal:  Br J Clin Pharmacol       Date:  2006-04       Impact factor: 4.335

6.  How much monitoring?

Authors:  Paul Glasziou
Journal:  Br J Gen Pract       Date:  2007-05       Impact factor: 5.386

7.  Use of randomised trials to decide when to monitor response to new treatment.

Authors:  Katy J L Bell; Les Irwig; Jonathan C Craig; Petra Macaskill
Journal:  BMJ       Date:  2008-02-16

Review 8.  A strategy for regulatory action when new adverse effects of a licensed product emerge.

Authors:  Jeffrey K Aronson; Deirdre Price; Robin E Ferner
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 9.  Monitoring in clinical biochemistry.

Authors:  Jenny Doust; Paul Glasziou
Journal:  Clin Biochem Rev       Date:  2013-08

10.  Accessibility, clinical effectiveness, and practice costs of providing a telephone option for routine asthma reviews: phase IV controlled implementation study.

Authors:  Hilary Pinnock; Lorraine Adlem; Suzanne Gaskin; Jan Harris; Caroline Snellgrove; Aziz Sheikh
Journal:  Br J Gen Pract       Date:  2007-09       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.